A Prospective, Multicenter, Open-label Trial of Zoledronic Acid in Patients with Hormone Refractory Prostate Cancer

PURPOSE: The short-term safety and efficacy of zoledronic acid for the treatment of skeletal metastasis was evaluated in patients with hormone-refractory prostate cancer. PATIENTS AND METHODS: A total of 19 hormone-refractory prostate cancer patients with bone metastases were enrolled. All patients...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hong, Sung Joon, Cho, Kang Su, Choi, Han Yong, Ahn, Hanjong, Kim, Choung-Soo, Chung, Byung Ha
Formato: Artigo
Idioma:Inglês
Publicado em: Yonsei University College of Medicine 2007
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2628173/
https://ncbi.nlm.nih.gov/pubmed/18159593
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2007.48.6.1001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados